James Papadakis was two years into his battle with Parkinson's disease and his symptoms had taken a turn for the worse when his Baylor College of Medicine doctor suggested an experimental new skin ...

(Reuters) -Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease drug Neupro, clearing an obstacle for Teva's ...

BRUSSELS, June 4 (Reuters) - Belgian pharmaceutical group UCB said on Wednesday it had found a solution to a problem affecting its Parkinson's patch Neupro -- storing them in a fridge. UCB said in a ...

The treatment options for patients with early Parkinson’s expanded Wednesday with the approval of a new drug in patch form — a first for medicines to treat symptoms of the disease. The once-daily ...